GlassScriptPhysician profile
Richard Paluzzi
NPI 1497701205
$1,598.57
in general payments reported to CMS, 2019-2025
10 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.09 · 2022: $59.06 · 2023: $162 · 2024: $1,159 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $953 · Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $953.30 |
| Food and Beverage | $545.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,142.18 | 2024 | Chromophare F300, N/A |
| Madrigal Pharmaceuticals | $141.23 | 2025 | Rezdiffra |
| Novo Nordisk INC | $110.71 | 2022-2025 | Rybelsus, Ozempic |
| Lundbeck LLC | $48.09 | 2023 | Rexulti |
| Astellas Pharma US INC | $41.09 | 2021 | |
| Lilly USA, LLC | $34.80 | 2023-2024 | Jardiance, Emgality, Zepbound |
| Pfizer INC. | $30.55 | 2022 | |
| Exact Sciences Corporation | $18.96 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $15.76 | 2023 | Gardasil 9 |
| Teva Pharmaceuticals USA, INC. | $15.20 | 2023 | Airduo Digihaler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Paluzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.